HYDROXYCHLOROQUINE SULFATE Drug Patent Profile

When do Hydroxychloroquine Sulfate patents expire, and when can generic versions of Hydroxychloroquine Sulfate launch?

Hydroxychloroquine Sulfate is a drug marketed by Accord Hlthcare, Alkaloida Zrt, Amneal Pharms Co, Appco, Aurobindo Pharma Usa, Chartwell Rx, Creekwood Pharms, Hikma Pharms, Ipca Labs Ltd, Laurus, Sandoz, Senores Pharms, Teva Pharms, Watson Labs, and Zydus Pharms Usa Inc. and is included in fifteen NDAs.

The generic ingredient in HYDROXYCHLOROQUINE SULFATE is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Hydroxychloroquine Sulfate

A generic version of HYDROXYCHLOROQUINE SULFATE was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30^th, 1994.

Summary for HYDROXYCHLOROQUINE SULFATE

US Patents:	0
Applicants:	15
NDAs:	15
Finished Product Suppliers / Packagers:	25
Raw Ingredient (Bulk) Api Vendors:	122
Clinical Trials:	46
Patent Applications:	2,399
Drug Sales Revenues:	Drug sales revenues for HYDROXYCHLOROQUINE SULFATE
What excipients (inactive ingredients) are in HYDROXYCHLOROQUINE SULFATE?	HYDROXYCHLOROQUINE SULFATE excipients list
DailyMed Link:	HYDROXYCHLOROQUINE SULFATE at DailyMed

See drug sales revenues for HYDROXYCHLOROQUINE SULFATE

Recent Clinical Trials for HYDROXYCHLOROQUINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Henan Cancer Hospital	Phase 2
West Virginia University	Phase 1/Phase 2
Translational Breast Cancer Research Consortium	Phase 2

See all HYDROXYCHLOROQUINE SULFATE clinical trials

Pharmacology for HYDROXYCHLOROQUINE SULFATE

Drug Class

Antimalarial Antirheumatic Agent

Medical Subject Heading (MeSH) Categories for HYDROXYCHLOROQUINE SULFATE

Antimalarials

Antirheumatic Agents

Enzyme Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for HYDROXYCHLOROQUINE SULFATE

P01BA	Aminoquinolines
P01B	ANTIMALARIALS
P01	ANTIPROTOZOALS
P	Antiparasitic products, insecticides and repellents

P01BA	Aminoquinolines
P01B	ANTIMALARIALS
P01	ANTIPROTOZOALS
P	Antiparasitic products, insecticides and repellents

US Patents and Regulatory Information for HYDROXYCHLOROQUINE SULFATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	HYDROXYCHLOROQUINE SULFATE	hydroxychloroquine sulfate	TABLET;ORAL	213342-002	Aug 18, 2021	AB	RX	No	No
Senores Pharms	HYDROXYCHLOROQUINE SULFATE	hydroxychloroquine sulfate	TABLET;ORAL	212902-001	May 14, 2020	AB	RX	No	No
Appco	HYDROXYCHLOROQUINE SULFATE	hydroxychloroquine sulfate	TABLET;ORAL	210441-002	Sep 19, 2022	AB	RX	No	Yes
Accord Hlthcare	HYDROXYCHLOROQUINE SULFATE	hydroxychloroquine sulfate	TABLET;ORAL	213342-004	Aug 18, 2021	AB	RX	No	Yes
Chartwell Rx	HYDROXYCHLOROQUINE SULFATE	hydroxychloroquine sulfate	TABLET;ORAL	210543-001	Jul 6, 2018	AB	RX	No	No
Watson Labs	HYDROXYCHLOROQUINE SULFATE	hydroxychloroquine sulfate	TABLET;ORAL	040133-001	Nov 30, 1995		DISCN	No	No